gvtcx

NHS National Generic Pharmaceuticals Transition 2023_1

NHS England Published 11 Jan 2023 Contracts Finder

key details

Value£104,188,007
Statusactive
Category (CPV) 33600000
RegionEast Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber
Deadline17 Feb 2023
Contract start1 Aug 2023
Contract end31 Jan 2025
Procedureopen
SME suitableYes
OCIDocds-b5fd17-7806195d-f2e7-4f5a-bb99-be037298088e

description

Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1

Offer reference number: CM/PHG/22/5666

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

CM/PHG/22/5666/00 - Transition Products:

CESW01/08/2023 - 31/01/2024 (6 months)
NWLN01/08/2023 - 31/01/2025 (18 months)
LSNE01/08/2023 - 31/05/2024 (10 months)

CM/PHG/22/5666/01 - Orals Oral (plus non-parenteral) Products:

All regions: 01/08/2023 to 31/05/2024 (10 months)

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
11 Jan 2023 Tender (tender) · e3531e7e-856a-43fc-a13a-9961bac44ce3-604856

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.